| Income Statement |
| Total Revenue | 3.61B |
|
| Revenues (USD) | 3.61B |
| Cost of Revenue | 633.00M |
| Gross Profit | 2.98B |
| Operating Expenses | 2.22B |
| Research and Development Expense | 672.00M |
| Selling, General and Administrative Expense | 1.18B |
| Operating Income | 758.00M |
| Interest Expense | 37.00M |
| Income Tax Expense | 81.00M |
| Net Income | 816.00M |
| Net Income Common Stock | 816.00M |
| Net Income Common Stock (USD) | 816.00M |
| Consolidated Income | 816.00M |
| Earnings per Basic Share | 1.38 |
| Earnings per Basic Share (USD) | 1.38 |
| Earnings per Diluted Share | 1.37 |
| Earning Before Interest & Taxes (EBIT) | 934.00M |
| Earning Before Interest & Taxes (USD) | 934.00M |
| Weighted Average Shares | 592.00M |
| Weighted Average Shares Diluted | 597.00M |
| Balance Sheet |
| Cash and Equivalents | 6.82B |
| Cash and Equivalents (USD) | 6.82B |
| Investments | 5.25B |
| Investments Current | 5.25B |
| Trade and Non-Trade Receivables | 12.22B |
| Current Assets | 25.48B |
| Total Assets | 28.75B |
| Total Debt | 2.48B |
| Current Liabilities | 18.09B |
| Debt Non-Current | 2.48B |
| Total Liabilities | 20.96B |
| Accumulated Retained Earnings (Deficit) | -6.65B |
| Accumulated Other Comprehensive Income | 19.00M |
| Shareholders Equity | 7.80B |
| Shareholders Equity (USD) | 7.80B |
| Assets Non-Current | 3.28B |
| Total Debt (USD) | 2.48B |
| Deferred Revenue | 2.83B |
| Goodwill and Intangible Assets | 765.00M |
| Liabilities Non-Current | 2.86B |
| Trade and Non-Trade Payables | 12.22B |
| Tax Assets | 1.91B |
| Cash Flow |
| Net Cash Flow from Financing | 571.00M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.46B |
| Issuance (Purchase) of Equity Shares | -978.00M |
| Issuance (Repayment) of Debt Securities | -5.00M |
| Net Cash Flow from Investing | -349.00M |
| Net Cash Flow - Investment Acquisitions and Disposals | -292.00M |
| Net Cash Flow from Operations | 1.27B |
| Effect of Exchange Rate Changes on Cash | -28.00M |
| Share Based Compensation | 487.00M |